Emblem raises $53 million through bought-deal financing

Toronto-based medical cannabis producer Emblem Corp. (TSXV:EMC) (EMC.WT) closed its previously announced bought deal offering, including the over-allotment. It issued 14,024,391 units and 25,000 8.0% convertible unsecured debentures due in 2021. Total gross proceeds were $53,750,001.55.

The proceeds will be used for a new facility, comprised of 3.1 acres of greenhouse and .8 acres of infrastructure. Remaining funds will be for pharmaceutical formulation development, including research and trials, and for general working capital purposes.

Emblem has three verticals – cannabis production, patient education centers, and pharmaceutical dosage form development.

After the offering, Emblem will have a cash and cash equivalents balance of approximately $87,000,000.

Each unit consists of one common share and one common share purchase warrant. The units sold at $2.05 raising $28,750,001.55. The debentures sold at $1,000 each raising $25,000,000. The warrants entitle a holder to buy an additional common share at $2.70 until February 2, 2020. The Debentures offer 8.00% interest payable semi-annually, maturing on February 2, 2021.

Emblem can require conversion of debentures on not less than thirty days’ notice if the weighted average trading price is greater than $3.45 for any ten consecutive trading days.

The company also announced that holders of $15,000,000 of its previously issued convertible debentures due November 16, 2020 converted their debentures into common shares at the stated conversion price of $1.95 per share. In connection with the conversion, Emblem issued 7,692,307 Common shares to the debenture holders.

Source Emblem press release

Emblem raises $53 million through bought-deal financing

About Cannin.com: Your Marijuana Stocks Resource

Cannin is your #1 resource for marijuana stocks. Our global team of experts evaluates all emerging marijuana stock investing opportunities. We aggregate hundreds of hours of research and provide tips on the best marijuana stock investments for 2020.

Use Cannin as your resource for:

Is it too late to invest in marijuana stocks? No! This is the perfect time to invest.

Many market analysts expect the legal marijuana industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in marijuana stocks is now.

Are you interested in marijuana stocks like Curaleaf, Trulieve, Aurora Cannabis, or Charlotte’s Web,?

Are you looking to buy stock in marijuana companies for 2020? Interested in emerging penny marijuana stocks? Looking for the best Canadian marijuana stocks to invest in? We can help.

Predict price movements of marijuana stocks several hours in advance with our proprietary algorithmic stock trading software.

+25% Gains in 2020
+49.8% Gains in 2019
108% Backtested since 2012

We’re so confident you’ll love our algotrading marijuana stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.

Profit from the best marijuana stocks – we’ll show you how at cannin.com.

Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Best Hemp Stocks 2020

Emblem raises $53 million through bought-deal financing